201
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Gambogic acid-loaded PEG–PCL nanoparticles act as an effective antitumor agent against gastric cancer

, , , , , , & show all
Pages 33-40 | Received 10 Nov 2016, Accepted 08 Jan 2017, Published online: 03 Mar 2017

References

  • Aigner KR, Stephens FO. 2011. Induction chemotherapy: integrated treatment programs for locally advanced cancers. Berlin, Germany: Springer Science & Business Media.
  • Blanco E, Sangai T, Hsiao A, Ferrati S, Bai L, Liu X, Meric-Bernstam F, Ferrari M. 2013. Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment. Cancer Lett. 334:245–252.
  • Colby AH, Liu R, Schulz MD, Padera RF, Colson YL, Grinstaff MW. 2016. Two-step delivery: exploiting the partition coefficient concept to increase intratumoral paclitaxel concentrations in vivo using responsive nanoparticles. Sci Rep. 6:18720.
  • Diao YY, Li HY, Fu YH, Han M, Hu YL, Jiang HL, Tsutsumi Y, Wei QC, Chen DW, Gao JQ. 2011. Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells. Int J Nanomedicine. 6:1955–1962.
  • Gao H, Hu G, Zhang Q, Zhang S, Jiang X, He Q. 2014. Pretreatment with chemotherapeutics for enhanced nanoparticles accumulation in tumor: the potential role of G2 cycle retention effect. Sci Rep. 4:4492.
  • Glasgow MD, Chougule MB. 2015. Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging. J Biomed Nanotechnol. 11:1859–1898.
  • Gong H, Chao Y, Xiang J, Han X, Song G, Feng L, Liu J, Yang G, Chen Q, Liu Z. 2016. Hyaluronidase to enhance nanoparticle-based photodynamic tumor therapy. Nano Lett. 16:2512–2521.
  • Gou M, Wei X, Men K, Wang B, Luo F, Zhao X, Wei Y, Qian Z. 2011. PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery. Curr Drug Targets. 12:1131–1150.
  • Harada Y, Yamamoto T, Sakai M, Saiki T, Kawano K, Maitani Y, Yokoyama M. 2011. Effects of organic solvents on drug incorporation into polymeric carriers and morphological analyses of drug-incorporated polymeric micelles. Int J Pharm. 404:271–280.
  • Huang H, Chen D, Li S, Li X, Liu N, Lu X, Liu S, Zhao K, Zhao C, Guo H, et al. 2011. Gambogic acid enhances proteasome inhibitor-induced anticancer activity. Cancer Lett. 301:221–228.
  • Huang YC, Kuo CL, Lu KW, Lin JJ, Yang JL, Wu RS, Wu PP, Chung JG. 2016. Glycyrrhetinic acid induces apoptosis of HL-60 human leukemia cells through caspases- and mitochondria-dependent signaling pathways. Molecules. 21:18.
  • Janicke RU, Sprengart ML, Wati MR, Porter AG. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 273:9357–9360.
  • Kim R. 2005. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer. 103:1551–1560.
  • Krukiewicz K, Zak JK. 2016. Biomaterial-based regional chemotherapy: Local anticancer drug delivery to enhance chemotherapy and minimize its side-effects. Mater Sci Eng C Mater Biol Appl. 62:927–942.
  • Lewis SL, Dirksen SR, Heitkemper MM, Bucher L. 2014. Medical-surgical nursing: assessment and management of clinical problems, single volume. Holland: Elsevier Health Sciences.
  • Li K, Liu H, Gao W, Chen M, Zeng Y, Liu J, Xu L, Wu D. 2015a. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy. Biomaterials. 39:131–144.
  • Li Q, Lai KL, Chan PS, Leung SC, Li HY, Fang Y, To KK, Choi CH, Gao QY, Lee TW. 2016. Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium. Colloids Surf B Biointerfaces. 140:278–286.
  • Li R, Li X, Xie L, Ding D, Hu Y, Qian X, Yu L, Ding Y, Jiang X, Liu B. 2009. Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery. Int J Pharm. 379:158–166.
  • Li Y, Liu R, Yang J, Shi Y, Ma G, Zhang Z, Zhang X. 2015b. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. Biomaterials. 41:1–14.
  • Liu J, Luo Z, Zhang J, Luo T, Zhou J, Zhao X, Cai K. 2016. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy. Biomaterials. 83:51–65.
  • Nishiyama N, Kataoka K. 2006. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther. 112:630–648.
  • Philchenkov A, Zavelevich M, Kroczak TJ, Los M. 2004. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol. 26:82–97.
  • Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S. 2009. Amphiphilic multi-arm- block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Biomaterials. 30:5757–5766.
  • Ryu JH, Bickerton S, Zhuang J, Thayumanavan S. 2012. Ligand-decorated nanogels: fast one-pot synthesis and cellular targeting. Biomacromolecules. 13:1515–1522.
  • Savic R, Luo L, Eisenberg A, Maysinger D. 2003. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science. 300:615–618.
  • Sharma G, Park J, Sharma AR, Jung JS, Kim H, Chakraborty C, Song DK, Lee SS, Nam JS. 2015. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer. Pharm Res. 32:723–735.
  • Shen Y, Leng M, Yu H, Zhang Q, Luo X, Gregersen H, Wang G, Liu X. 2015. Effect of amphiphilic PCL-PEG nano-micelles on HepG2 cell migration. Macromol Biosci. 15:372–384.
  • Shi X, Lan X, Chen X, Zhao C, Li X, Liu S, Huang H, Liu N, Zang D, Liao Y, et al. 2015. Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition. Sci Rep. 5:9694.
  • Thambi T, Park JH. 2014. Recent advances in shell-sheddable nanoparticles for cancer therapy. J Biomed Nanotechnol. 10:1841–1862.
  • Wang J, Ma J, You Q, Zhao L, Wang F, Li C, Guo Q. 2010. Studies on chemical modification and biology of a natural product, gambogic acid (II): synthesis and bioevaluation of gambogellic acid and its derivatives from gambogic acid as antitumor agents. Eur J Med Chem. 45:4343–4353.
  • Wang T, Wei J, Qian X, Ding Y, Yu L, Liu B. 2008. Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. Cancer Lett. 262:214–222.
  • Wolinsky JB, Colson YL, Grinstaff MW. 2012. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release. 159:14–26.
  • Wu P, Liu Q, Li R, Wang J, Zhen X, Yue G, Wang H, Cui F, Wu F, Yang M, et al. 2013. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. ACS Appl Mater Interfaces. 5:12638–12645.
  • Xin H, Sha X, Jiang X, Zhang W, Chen L, Fang X. 2012. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials. 33:8167–8176.
  • Xu L, Xu X, Chen H, Li X. 2013. Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye. Colloids Surf B Biointerfaces. 112:30–34.
  • Yao J, Li Y, Sun X, Dahmani FZ, Liu H, Zhou J. 2014. Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid. Int J Nanomedicine. 9:3313–3324.
  • Zhang W, Shi Y, Chen Y, Yu S, Hao J, Luo J, Sha X, Fang X. 2010. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. Eur J Pharm Biopharm. 75:341–353.
  • Zhang Y, Yang C, Wang W, Liu J, Liu Q, Huang F, Chu L, Gao H, Li C, Kong D, et al. 2016. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep. 6:21225.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.